HomeCONGRESS

CONGRESS

View Category
HIGHLIGHTS

CANTOS: Anti-inflammatory Drug Canakinumab Seems to Reduce CV Events

This human monoclonal antibody that specifically targets inflammatory cells seems to reduce cardiovascular events when associated with...
solaci -
Learn More
Acute coronary syndromes

VALIDATE-SWEDEHEART: bivalirudin seems to be losing ground

Another important work that does not see the benefits of bivalirudin over heparin as monotherapy as regards both...
solaci -
Learn More
HIGHLIGHTS

SPYRAL HTN-OFF MED: Renal Denervation Reloaded?

This work presented at the ESC Congress 2017 held in Barcelona, simultaneously published in The Lancet, seems to...
solaci -
Learn More
Antithrombotic Anticoagulants

RE-DUAL PCI: Anti-Thrombotic Management in Patients with Atrial Fibrillation and PCI

RE-DUAL PCI outcomes have been published by the  New England Journal of Medicine along with their presentation at...
solaci -
Learn More
ESC 2017

ESC 2017

Here you will find the highlights of ESC 2017, held on August 26-30 in Barcelona, Spain. If you cannot view...
solaci -
Learn More
Institutional News

SOLACI-CACI Congress: a summary with images (2nd part)

The event took place at the Buenos Aires Hilton Hotel, between 2-4 August.
solaci -
Learn More
Congress News

President Dr. José Luis Leiva Pons Has Taken Office

SOLACI has a new president! Dr. José Luis Leiva Pons (Mexico) has taken over the reins of...
solaci -
Learn More
Congress News

SOLACI-CACI 2017: All Winners

See the list of winners for all contests carried out as part of the last SOLACI-CACI 2017 Congress....
solaci -
Learn More